Skip to content
Clinical Trials – home

Sygehus Lillebaelt Vejle Sygehus

Verified siteinfo

Denmark Beriderbakken 4, 7100 Vejle, Denmark

  • 54 trials recruiting
  • Chronic obstructive pulmonary disease · Plasma cell myeloma · Asthma
  • Adults and children

About Specializations

Sygehus Lillebaelt Vejle Sygehus in Vejle, Denmark specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Plasma cell myeloma, Asthma, Colorectal cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Hematology and Oncology Research

At Sygehus Lillebaelt Vejle Sygehus, clinical trials in hemic and lymphatic diseases and neoplasms focus on improving care for blood cancers and other malignancies. The studies are designed to test new treatment strategies, compare existing therapies, and better understand how to control disease progression and support patient outcomes.

  • Research in multiple myeloma is evaluating ways to reduce infections and early complications in patients who are newly diagnosed and not eligible for transplant.
  • Trials in diffuse large B-cell lymphoma are comparing treatment approaches to improve disease control and extend progression-free survival.
  • Studies in triple-negative breast cancer are assessing whether new combinations can offer better effectiveness than current standard options.
  • Work in metastatic hormone-sensitive prostate cancer is examining whether adding a targeted therapy can improve control of advanced disease.

This research portfolio reflects a strong focus on finding more effective and better-tolerated cancer treatments through collaborative clinical investigation.

Respiratory and Inflammatory Disease Studies

The site is also active in respiratory tract diseases and immune-related conditions, with trials aimed at improving symptom control and reducing reliance on standard medications. These studies explore new therapies for chronic inflammatory disease while also looking at safety and patient benefit.

  • In pulmonary sarcoidosis, researchers are testing a new therapy to assess safety, tolerability, and its ability to lower corticosteroid use.
  • The studies are focused on finding better ways to manage persistent inflammation and improve day-to-day functioning for people with this condition.

This area of research highlights the hospital’s interest in advancing treatment options for complex lung disease and related systemic involvement.

Musculoskeletal and Orthopedic Care

Clinical research in musculoskeletal diseases at this hospital includes studies on pain relief, recovery, and patient comfort after joint surgery. The trials are aimed at improving postoperative care and identifying the safest and most effective ways to support mobility and healing.

  • Research in hip and knee arthroplasties is evaluating pain management approaches after major orthopedic surgery.
  • Studies in acute postoperative pain are examining how different treatment strategies can improve recovery after surgery.
  • Trials comparing anesthesia approaches are looking at early mobility and faster functional recovery after joint replacement.

These projects aim to make orthopedic procedures safer, less painful, and easier to recover from for patients undergoing joint replacement.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Beriderbakken 47100 VejleDenmark
Recruiting now
54 trials
Conditions studied
81
Partner status
Verified site

More sites in VejleDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

143 clinical trials

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC

Asthma

Recruiting

Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:JNJ-77242113
  • Sponsor:Janssen Cilag International

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S

Study of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Healthcare KGaA

Cevostamab, Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 1‑3 Lines of Therapy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:F. Hoffmann-La Roche AG

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Incyte Corp.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.